PatientsLikeMe ™

MS
Skip over navigation
Join Now (It's free!)

Already a member? Log in

Share your real-world treatment experience
with patients just like you.
Filter page content by community
MS
Find out more about the PatientsLikeMe
MS Community

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Brand Names: Trileptal
Generic Name: Oxcarbazepine

What is Oxcarbazepine? Oxcarbazepine is used to treat certain types of seizures in people who have epilepsy. It is an anticonvulsant. It works by decreasing abnormal excitement in the brain. Read more...Click to read more below

See more information, including instructions, precautions, side effects, and interactions.


Reasons Taken

46 patients in the community are taking or have taken Oxcarbazepine.

Reason # Patients Percentage of patients
Other 15 32%
Pain 10 21%
Trigeminal neuralgia (tic douloureux) 6 13%
Stiffness/spasticity 4 8%
Pain: mid-back (bra-strap area) 2 4%
Neuro pain, left arm 2 4%
Slow my MS progress 2 4%
Mood swings 2 4%
Emotional lability 2 4%
trigeminal neuralgia 1 2%

Dosages

Based on the patients currently taking Oxcarbazepine.

  0 day 0 mg none 150 mg day 300 mg day 450 mg day 600 mg day 700 mg day 900 mg day 1200 mg day 1800 mg day
  2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 5 Number of Patients: 5 4 Number of Patients: 4 15 Number of Patients: 15 1 Number of Patients: 1 5 Number of Patients: 5 3 Number of Patients: 3 4 Number of Patients: 4  

Duration

How long current patients have been taking Oxcarbazepine or how long patients were taking Oxcarbazepine before stopping.

Currently taking Oxcarbazepine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
5
5
6
5
10

Stopped taking Oxcarbazepine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
2
1
1
0
Why Patients Stopped Taking Oxcarbazepine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 2 33% Doctor's advice: 33%
Course of treatment ended 2 33% Course of treatment ended: 33%
Did not seem to work 1 17% Did not seem to work: 17%
Side effects too severe 1 17% Side effects too severe: 17%
Other 1 17% Other: 17%


Back to top